- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jasper Therapeutics Inc (JSPR)
Jasper Therapeutics Inc stock price live, this page displays NASDAQ JSPR stock exchange data. View the JSPR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jasper Therapeutics Inc real time stock price chart below.
What Is the Jasper Therapeutics Inc Stock Price Today?
The Jasper Therapeutics Inc stock price today is 2.980.
What Is the Stock Symbol for Jasper Therapeutics Inc?
The stock symbol for Jasper Therapeutics Inc is ""JSPR.""
What Stock Exchange Does Jasper Therapeutics Inc Trade On?
Jasper Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Jasper Therapeutics Inc a Good Stock to Buy?
Determining whether Jasper Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JSPR quote. (ISIN: US4718712023)
What Is the Jasper Therapeutics Inc Stock Price Today?
The Jasper Therapeutics Inc stock price today is 2.980.
What Is the Stock Symbol for Jasper Therapeutics Inc?
The stock symbol for Jasper Therapeutics Inc is ""JSPR.""
What Stock Exchange Does Jasper Therapeutics Inc Trade On?
Jasper Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Jasper Therapeutics Inc a Good Stock to Buy?
Determining whether Jasper Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JSPR quote. (ISIN: US4718712023)
NASDAQ
Currency in USD
2.980
+0.010(+0.34%)
Closed·
After Hours
3.050+0.070(+2.35%)
·
Fair Value
An estimate of a Jasper Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.910
3.040
52 wk Range
2.265
26.050
JSPR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
JSPR is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Jasper Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.9103.040
52 wk Range
2.26526.050
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
JSPR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Jasper Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
20.125
Upside
+575.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Jasper Therapeutics Inc Company Profile
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Jasper Therapeutics Inc SWOT Analysis
Briquilimab's Promise | Explore Jasper Therapeutics' lead candidate briquilimab, showing potential in treating chronic spontaneous urticaria with promising clinical trial results |
Market Opportunity | Delve into the substantial CSU market, with over 3 million U.S. patients and limited treatment options, positioning briquilimab for significant impact |
Financial Landscape | Analysts set price targets ranging from $15 to $70, reflecting varied perspectives on Jasper's potential in the competitive biotech landscape |
Future Catalysts | Upcoming trial data releases could significantly influence Jasper's stock performance, with Q3 2025 BEACON study results as a key milestone |
Compare JSPR to Peers and Sector
Metrics to compare | JSPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJSPRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −2.4x | −0.5x | |
PEG Ratio | −0.11 | −0.03 | 0.00 | |
Price/Book | 1.1x | 0.9x | 2.6x | |
Price / LTM Sales | - | 64.4x | 3.3x | |
Upside (Analyst Target) | - | 349.7% | 42.8% | |
Fair Value Upside | Unlock | 22.1% | 6.5% | Unlock |
Analyst Ratings
6 Buy
4 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 20.125
(+575.34% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-1.41 / -1.80
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Jasper Therapeutics Trade On?
Jasper Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Jasper Therapeutics?
The stock symbol for Jasper Therapeutics is "JSPR."
What Is the Jasper Therapeutics Market Cap?
As of today, Jasper Therapeutics market cap is 44.77M.
What Is Jasper Therapeutics's Earnings Per Share (TTM)?
The Jasper Therapeutics EPS (TTM) is -5.25.
From a Technical Analysis Perspective, Is JSPR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jasper Therapeutics Stock Split?
Jasper Therapeutics has split 1 times.
How Many Employees Does Jasper Therapeutics Have?
Jasper Therapeutics has 64 employees.
What is the current trading status of Jasper Therapeutics (JSPR)?
As of 06 Aug 2025, Jasper Therapeutics (JSPR) is trading at a price of 2.98, with a previous close of 2.98. The stock has fluctuated within a day range of 2.91 to 3.04, while its 52-week range spans from 2.27 to 26.05.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.